| Literature DB >> 30258227 |
Linda Lorenz1,2,3, Jennifer Axnick1, Tobias Buschmann1,4, Carina Henning1, Sofia Urner1, Shentong Fang5, Harri Nurmi5, Nicole Eichhorst4, Richard Holtmeier6,7, Kálmán Bódis3,8,9, Jong-Hee Hwang8,9, Karsten Müssig3,8,9, Daniel Eberhard1, Jörg Stypmann6,7, Oliver Kuss3,10, Michael Roden3,8,9, Kari Alitalo5, Dieter Häussinger4, Eckhard Lammert11,12,13.
Abstract
Angiocrine signals derived from endothelial cells are an important component of intercellular communication and have a key role in organ growth, regeneration and disease1-4. These signals have been identified and studied in multiple organs, including the liver, pancreas, lung, heart, bone, bone marrow, central nervous system, retina and some cancers1-4. Here we use the developing liver as a model organ to study angiocrine signals5,6, and show that the growth rate of the liver correlates both spatially and temporally with blood perfusion to this organ. By manipulating blood flow through the liver vasculature, we demonstrate that vessel perfusion activates β1 integrin and vascular endothelial growth factor receptor 3 (VEGFR3). Notably, both β1 integrin and VEGFR3 are strictly required for normal production of hepatocyte growth factor, survival of hepatocytes and liver growth. Ex vivo perfusion of adult mouse liver and in vitro mechanical stretching of human hepatic endothelial cells illustrate that mechanotransduction alone is sufficient to turn on angiocrine signals. When the endothelial cells are mechanically stretched, angiocrine signals trigger in vitro proliferation and survival of primary human hepatocytes. Our findings uncover a signalling pathway in vascular endothelial cells that translates blood perfusion and mechanotransduction into organ growth and maintenance.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30258227 DOI: 10.1038/s41586-018-0522-3
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962